Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic malignancy classified by WHO and marked by cutaneous lesions, bone marrow infiltration, and CNS involvement.
ITWeb on MSN
Cell C to be worth as much as R12bn on listing
Cell C to be worth as much as R12bn on listing By Nicola Mawson, Contributing journalistJohannesburg, 13 Nov 2025Blu Label Unlimited, through The Prepaid Company, will continue to hold a share of Cell ...
Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a ...
An AI tool that can analyze abnormalities in the shape and form of blood cells, and with greater accuracy and reliability ...
A small label installed on a wire when a giant cargo ship was built may have triggered a chain of events nearly a decade ...
Trial met primary endpoint of hemoglobin response and key secondary endpoints of change from baseline in hemoglobin concentration and indirect ...
One small compartment inside the nucleus has come into focus with regards to aging: the nucleolus. Its main job is simple and ...
South African mobile operator Cell C and The Prepaid Company (TPC) are targeting gross proceeds of up to 6.5 billion rand ($375 million) from the sale of shares ahead of Cell C's planned listing on ...
The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA AND JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH ...
Pain is a constant, complex companion that clinicians often struggle to understand and measure for people living with sickle ...
University of Tokyo researchers have created a powerful new microscope that captures both forward- and back-scattered light ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback